LEAD试验:面向丹麦低教育程度未参加FIT结直肠癌筛查公民的决策辅助工具效果研究方案
LEAD试验是一项双臂随机对照试验,计划在丹麦中央丹麦大区纳入10,000名50–74岁、尚未受邀参加结直肠癌筛查的公民,评估新开发的自助式决策辅助工具对低教育程度公民知情选择的效果。研究以知识、态度和筛查参与率评价知情选择,并采用意向性治疗分析,同时评估担忧程度与决策冲突作为次要结局。
要点
- 针对低教育程度公民开发自助式决策辅助工具,以促进结直肠癌筛查的知情选择
- 主要评价指标为知识、态度与筛查参与率,采用意向性治疗分析
- 担忧程度与决策冲突作为次要结局评估
核心结论
- 该试验将评估针对性决策辅助工具是否是提升低教育程度公民结直肠癌筛查知情选择的可行方式,并可能为癌症筛查信息材料的提供决策提供参考。
研究设计与样本
- 双臂随机对照试验,计划纳入10,000名50–74岁、居住于中央丹麦大区且尚未受邀参加结直肠癌筛查的公民。
- 公民先填写基线问卷,应答者被分配至干预组或对照组;干预组接受决策辅助工具,对照组不接受。
- 另纳入历史队列,由5,000名50–74岁中央丹麦大区公民组成,其于2017年初收到筛查邀请,并在收到邀请后6–9个月接受随访问卷。
- 在收到筛查邀请后45天内返还粪便样本者以及中等或更高教育程度者被排除。
- 两组均在受邀参加结直肠癌筛查后90天接受随访问卷,分析按意向性治疗进行。
主要发现
- 原文为研究方案,尚未报告试验结果。
关键数值与推荐
- 知情选择通过评估知识水平、态度和筛查参与率来评价。
- 担忧程度与决策冲突的组间差异作为次要结局评估。
- 试验注册号:ClinicalTrials.gov,NCT03253888,注册日期2017年8月17日。
临床怎么用
- 该决策辅助工具若被验证有效,可为低教育程度公民提供结直肠癌筛查信息支持,并可能指导癌症筛查信息材料的提供。
局限性
- 原文为研究方案,尚未提供有效性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colorectal cancer screening participation is a preference-sensitive choice, in which trade-offs between benefits and harms must be made by individual citizens. Often the decision is made without any contact with healthcare professionals. Citizens with lower educational attainment tend to participate less in colorectal cancer screening than citizens with average educational attainment. Further, they tend to have lower levels of knowledge about colorectal cancer screening. Providing lower educational attainment citizens with a targeted decision aid embracing their diverse information needs might increase these citizens' ability to make informed decisions. The aim of this trial is to test the effectiveness of such a newly developed self-administered decision aid. METHODS: The LEAD (Lower Educational Attainment Decision aid) trial will be conducted as a two-arm randomized controlled trial among 10,000 50-74-year-old citizens, resident in the Central Denmark Region not yet invited to take up colorectal cancer screening. Citizens will receive a baseline questionnaire. Respondents will be allocated into the intervention or the control groups. Citizens in the intervention group will receive the decision aid whereas the control group will not. Those who return a stool sample within 45 days after receiving the screening invitation and those with medium or higher educational attainment are excluded. Both groups will receive a follow-up questionnaire 90 days after being invited to colorectal cancer screening. A historic cohort consisting of 5000 50-74-year-old citizens resident in the Central Denmark Region, having received their screening invitation in the beginning of 2017 will be included. This cohort will receive a follow-up questionnaire 6-9 months after they received the screening invitation. Informed choice will be evaluated by assessing levels of knowledge, attitudes, and screening uptake. Analyses will be conducted as intention-to-treat analyses. Additionally, differences between levels of worry and decisional conflict between groups will be assessed as secondary outcomes. DISCUSSION: This trial will evaluate whether a targeted decision aid is a feasible way of enhancing informed choice among lower educational attainment citizens in colorectal cancer screening. Further, it may guide decisions about providing information material in cancer screening in general. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03253888 . Registered on 17 August 2017.
引用
- Gabel P, Larsen MB, Kirkegaard P, et al. The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30305114. doi:10.1186/s13063-018-2921-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。